Speakers

Diego Möckli is Head of Supply Chain at Tigen Pharma, where he leads the manufacturing platform initiative to make CGT therapies faster, cheaper, more accessible and more sustainable. Before Tigen, he successfully held various leading supply chain positions in different industries, most recently at Novartis as Head of Logistics and Supply Chain. He has been instrumental in various key product launches and successfully introduced new operational standards and integrated business planning (IBP) locally and globally. Diego holds an engineering degree from ETH Zurich.

Presentation Title: Development and Supply of Personalized ATMPs – A Global Challenge

Abstract: The rise of cell and gene therapies has transformed the treatment of severe diseases. However, the current approach to developing these therapies requires significant changes. The current system is inadequate in terms of patient access, costs, speed, and environmental impact. Additionally, the gap between academia and industry needs to be addressed. It is no longer viable to ignore this issue, as all stakeholders aim to provide life-saving treatments to patients in a timely manner.

View company profile